E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer
Condition(s):Papillomavirus Infections; Oropharyngeal NeoplasmsLast Updated:February 24, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Papillomavirus Infections; Oropharyngeal NeoplasmsLast Updated:February 24, 2022Terminated
Condition(s):Oropharyngeal CancerLast Updated:August 29, 2019Completed
Condition(s):Radiofrequency ResectionLast Updated:March 25, 2020Completed
Condition(s):Head and Neck Cancer; Radiation Therapy Complication; Xerostomia; HyposalivationLast Updated:March 14, 2019Completed
Condition(s):PREDICTIVE BIOMARKERS; Evaluation of HPV-specific E5 Transcript Expression in a Cohort of Patients With HPV-associated OPC; HPV 16 Positive Oropharyngeal Tumors (OPC)Last Updated:October 24, 2023Recruiting
Condition(s):Carcinoma, Squamous Cell; Head and Neck Neoplasms; Oropharyngeal NeoplasmsLast Updated:September 14, 2023Active, not recruiting
Condition(s):Carcinoma, Squamous Cell; Head and Neck Neoplasms; Oropharyngeal NeoplasmsLast Updated:March 5, 2024Active, not recruiting
Condition(s):Carcinoma, Squamous Cell; Head and Neck Neoplasms; Oropharyngeal NeoplasmsLast Updated:May 4, 2017Terminated
Condition(s):Carcinoma, Squamous Cell; Head and Neck Neoplasms; Oropharyngeal NeoplasmsLast Updated:December 9, 2021Completed
Condition(s):OSA; Oral Disease; Oropharyngeal Neoplasms; Hypopharyngeal NeoplasmsLast Updated:March 16, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.